A detailed history of Arlington Financial Advisors, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Arlington Financial Advisors, LLC holds 761 shares of IDXX stock, worth $313,729. This represents 0.1% of its overall portfolio holdings.

Number of Shares
761
Previous 761 -0.0%
Holding current value
$313,729
Previous $370,000 3.78%
% of portfolio
0.1%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$468.04 - $548.53 $21,061 - $24,683
-45 Reduced 5.58%
761 $370,000
Q1 2023

May 05, 2023

BUY
$406.01 - $514.59 $99,472 - $126,074
245 Added 43.67%
806 $403,000
Q4 2022

Jan 18, 2023

BUY
$324.64 - $441.27 $182,123 - $247,552
561 New
561 $0
Q1 2022

Apr 26, 2022

SELL
$466.52 - $631.01 $145,087 - $196,244
-311 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$586.54 - $666.48 $182,413 - $207,275
311 New
311 $205,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.3B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Arlington Financial Advisors, LLC Portfolio

Follow Arlington Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Financial Advisors, LLC with notifications on news.